Studies | Disease | Frequency of SRSF2 |
|---|
[64] | JMML | 1.7% (2/116) |
[26] | JMML | 0% |
[65] | JMML | 3.7% (1/27) |
[69] | aCML | 0% (0/3) |
[70] | aCML | 12% (3/25) |
[78] | aCML | 40% (24/60) |
[67] | aCML | 34% (12/35) |
MDS/MPN-RS-T | 9% (4/45) |
[71] | RARS-T | 6.7% (5/75) |
[72] | RARS-T | 2% (1/48) |
[67] | MDS/MPN-U | 15% (6/39) |
- Abbreviations: MDS myelodysplasia, MPN myeloproliferative neoplasm, CMML Chronic Myelomonocytic Leukemia, JMML Juvenile Myelomonocytic Leukemia, aCML atypical Chronic Myeloid Leukemia, MPN/MDS-U unclassifiable MDS/MPN. * SRSF2 mutations in CMML are listed in a separate table
